First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Up 29.5% in February

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 31,210 shares, an increase of 29.5% from the January 29th total of 24,107 shares. Based on an average daily trading volume, of 74,476 shares, the days-to-cover ratio is presently 0.4 days. Approximately 3.0% of the company’s stock are short sold. Approximately 3.0% of the company’s stock are short sold. Based on an average daily trading volume, of 74,476 shares, the days-to-cover ratio is presently 0.4 days.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

Shares of FBT stock opened at $204.65 on Thursday. First Trust NYSE Arca Biotechnology Index Fund has a fifty-two week low of $141.38 and a fifty-two week high of $224.94. The firm has a market capitalization of $214.88 million, a price-to-earnings ratio of 21.72 and a beta of 0.65. The stock’s 50-day simple moving average is $211.76 and its 200-day simple moving average is $198.34.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of FBT. Dynamic Wealth Strategies LLC grew its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 10.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 515 shares of the company’s stock valued at $106,000 after buying an additional 50 shares during the last quarter. Kestra Private Wealth Services LLC grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 0.6% during the 4th quarter. Kestra Private Wealth Services LLC now owns 8,919 shares of the company’s stock valued at $1,842,000 after purchasing an additional 53 shares during the last quarter. Meridian Wealth Management LLC increased its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.5% in the third quarter. Meridian Wealth Management LLC now owns 3,552 shares of the company’s stock valued at $637,000 after purchasing an additional 54 shares during the period. Signaturefd LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 30.6% in the fourth quarter. Signaturefd LLC now owns 235 shares of the company’s stock worth $49,000 after purchasing an additional 55 shares during the last quarter. Finally, Bedell Frazier Investment Counselling LLC increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the 3rd quarter. Bedell Frazier Investment Counselling LLC now owns 3,200 shares of the company’s stock worth $574,000 after buying an additional 57 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.